Basilea Pharmaceutica Ltd (BPMUF)
44.45
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Basilea Pharmaceutica Price: 44.45 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
May 02, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
May 01, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 30, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 29, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 26, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 25, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 24, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 23, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 22, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 19, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 18, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 17, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 16, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 15, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 12, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 11, 2024 | 44.45 | 44.45 | 44.45 | 44.45 | 0.000 |
Apr 10, 2024 | 44.00 | 44.45 | 44.00 | 44.45 | 100.00 |
Apr 09, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 08, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 05, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 04, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 03, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 02, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Apr 01, 2024 | 40.75 | 40.75 | 40.75 | 40.75 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
36.59
Minimum
Aug 19 2019
61.00
Maximum
Feb 17 2021
48.20
Average
50.00
Median
May 15 2023
Price Benchmarks
AC Immune SA | 2.40 |
CRISPR Therapeutics AG | 57.06 |
Addex Therapeutics Ltd | 9.49 |
NLS Pharmaceutics Ltd | 0.137 |
Molecular Partners AG | 4.39 |
Price Related Metrics
PE Ratio | 66.07 |
PS Ratio | 3.246 |
Price to Free Cash Flow | 39.34 |
Earnings Yield | 1.51% |
Market Cap | 533.48M |
Operating PE Ratio | 23.76 |
Normalized PE Ratio | 66.07 |